Top 20 Startups & Unicorns companies in Monoclonal antibody by Highest Patent Value in the United States in 2019 – Discovery

Free Trial

The Monoclonal antibody top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Monoclonal antibody Startups & Unicorns in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.

Ranking Year:

Region:

Ranking:

1	STARTUP Eagle Biologics, Inc.	Massachusetts, United States	Viscosity,Health care,Pharmacy and Therapeutics, ...[+2]	Avg patent value: 9.08 M
2	UNICORN Intarcia Therapeutics, Inc.	California, United States	Medicine,Medical equipment,Health care, ...[+2]	Avg patent value: 8.43 M
3	STARTUP True North Therapeutics, Inc.	California, United States	Immunotherapy,Health care,Clinical trial, ...[+2]	Avg patent value: 8.02 M
4	STARTUP Boston Pharmaceuticals, Inc.	Massachusetts, United States	Biotechnology,Drug development,Biopharmaceutical, ...[+2]	Avg patent value: 6.24 M
5	STARTUP Forty Seven, Inc.	California, United States	Clinical trial,Medicine,Health care, ...[+2]	Avg patent value: 4.30 M
6	STARTUP Precision Biologics, Inc.	Texas, United States	Cancer vaccine,Pharmacy and Therapeutics,Biotechnology, ...[+2]	Avg patent value: 3.15 M
7	STARTUP CoImmune, Inc.	North Carolina, United States	Medicine,Pharmacy and Therapeutics,Cell therapy, ...[+2]	Avg patent value: 2.83 M
8	STARTUP Compass Therapeutics LLC	Massachusetts, United States	Pharmacy and Therapeutics,Monoclonal antibody,Antibody, ...[+2]	Avg patent value: 1.77 M
9	STARTUP Hibercell, Inc.	New York, United States	Dormancy,Primary tumor	Avg patent value: 1.33 M
10	STARTUP Namocell, Inc.	California, United States	Cell sorting,Biology,Systems design, ...[+2]	Avg patent value: 1.26 M
11	STARTUP Oncoc4, Inc.	United States	Biopharmaceutical	Avg patent value: 940,000
12	STARTUP Go Therapeutics, Inc.	Massachusetts, United States	Medicine,Health care,Cancer, ...[+2]	Avg patent value: 720,000
13	STARTUP Zumutor Biologics, Inc.	Massachusetts, United States	Antigen-presenting cell,Tumor microenvironment,Medicine, ...[+2]	Avg patent value: 698,571
14	STARTUP Thunder Biotech, Inc.	Utah, United States	Cancer,Oncology,Chemical engineering	Avg patent value: 540,000
15	STARTUP Viela Bio, Inc.	United States	B cell,Immunotherapy,Biotechnology, ...[+2]	Avg patent value: 435,294
16	STARTUP AskGene Pharma, Inc.	California, United States	Cytokine,Prodrug,Cytokine Therapy, ...[+1]	Avg patent value: 430,000
17	STARTUP Salubris Biotherapeutics, Inc.	United States	Antibody	Avg patent value: 100,000
18	STARTUP Inimmune Corp.	United States	Peanut allergy,Allergy drugs	Avg patent value: 99,000
19	STARTUP Acerta Pharma BV	California, United States	Medicine,Pharmacy and Therapeutics,Autoimmune disease, ...[+2]	Avg patent value: 90,000
20	STARTUP Dragonfly Therapeutics, Inc.	Massachusetts, United States	Pharmacy and Therapeutics,Biomedicine,Biotechnology, ...[+2]	Avg patent value: 62,288